Associations between intensity of RRT, inflammatory mediators, and outcomes

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 6, 2015, Pages 926-933

  Murugan, Raghavan ^a   Wen, Xiaoyan ^a   Keener, Christopher ^a,b   Pike, Francis ^a,b   Palevsky, Paul M ^a,c   Unruh, Mark ^a,d   Finkel, Kevin ^e   Vijayan, Anitha ^f   Elder, Michele ^a   Chen, Yi Fan ^a,b   Kellum, John A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^f WASHINGTON UNIVERSITY   (United States)

Author keywords

Apoptosis; Kidney disease; Renal failure

Indexed keywords

AUTACOID; DEATH RECEPTOR 5; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; APOPTOSIS REGULATORY PROTEIN; BIOLOGICAL MARKER;

ADULT; APACHE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD LEVEL; BLOOD SAMPLING; CLEVELAND CLINIC INTENSIVE CARE UNIT ACUTE RENAL FAILURE SCORE; CLINICAL TRIAL; COHORT ANALYSIS; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RENAL RECOVERY; RENAL REPLACEMENT THERAPY; RENAL SYSTEM PARAMETERS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; ADVERSE EFFECTS; AGED; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CONVALESCENCE; CRITICAL ILLNESS; GOVERNMENT; IMMUNOLOGY; KIDNEY; KIDNEY DISEASES; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; UNITED STATES;

AGED; APOPTOSIS REGULATORY PROTEINS; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; KIDNEY; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RENAL REPLACEMENT THERAPY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84930448509     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04560514     Document Type: Article

References (18)

1. Palevsky PM, Zhang JH,O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A,Watnick S, Star RA, Peduzzi P; VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7-20, 2008
2. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S; RENAL Replacement Therapy Study Investigators: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361: 1627-1638, 2009
3. Murugan R, Wen X, Shah N, Lee M, Kong L, Pike F, Keener C, UnruhM, Finkel K, Vijayan A, Palevsky PM, Paganini E, Carter M, Elder M, Kellum JA; Biological Markers for Recovery of Kidney (BioMaRK) Study Investigators: Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol Dial Transplant 29: 1854-1864, 2014
4. Ronco C, Recent evolution of renal replacement therapy in the critically ill patient. Crit Care 10:123, 2006
5. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 356: 26-30, 2000
6. Demirjian S, Chertow GM, Zhang JH, O'Connor TZ, Vitale J, Paganini EP, Palevsky PM; VA/NIH Acute Renal Failure Trial Network: Model to predict mortality in critically ill adults with acute kidney injury. Clin J Am Soc Nephrol 6: 2114-2120, 2011
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383, 1987
8. KnausWA,Draper EA,Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 13: 818- 829, 1985
9. Paganini EP, Halstenberg WK, Goormastic M: Risk modeling in acute renal failure requiring dialysis: The introduction of a new model. Clin Nephrol 46: 206-211, 1996
10. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsisrelated Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis- Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710, 1996
11. Su X, Tsai CL, Wang H, Nickerson DM, Li B: Subgroup analysis via recursive partitioning. J Mach Learn Res 10: 141-158, 2009
12. Wang CT, Ren HS, Jiang JJ, Zhang JC, Meng M, Yu JB, Chu YF, Ding M: [Study the effects of high-volume hemofiltration and fluid resuscitation on removing blood lactic acid and proinflammatory cytokines in patients with refractory septic shock] [Chinese]. ZhongguoWei Zhong Bing Ji Jiu Yi Xue 21: 421-424, 2009
13. Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Müller JM, Baumann G, Kox WJ, Bellomo R, Neumayer HH: Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status.AmJ KidneyDis 43: 444-453, 2004
14. Kellum JA, Kong L, Fink MP,Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC; GenIMS Investigators: Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167: 1655- 1663, 2007
15. Yende S, D'Angelo G, Kellum JA,Weissfeld L, Fine J,Welch RD, Kong L, Carter M, Angus DC; GenIMS Investigators: Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med 177: 1242-1247, 2008
16. Casasnovas R-O, Mounier N, Brice P, DivineM, Morschhauser F, Gabarre J, Blay JY, Voillat L, Lederlin P, Stamatoullas A, Bienvenu J, GuiguetM, Intrator L,Grandjean M, Brière J, Ferme C, SallesG; Groupe d'Etude des Lymphomes de l'Adulte: Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: A study from the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 25: 1732- 1740, 2007
17. Al-Lamki RS,Wang J, Vandenabeele P, Bradley JA, Thiru S, LuoD, Min W, Pober JS, Bradley JR: TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury. FASEB J 19: 1637-1645, 2005
18. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS: Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 23: 507-515, 2012